Stage IVB Major Salivary Gland Carcinoma
3 clinical trials · Condition
◉ Watch Stage IVB Major Salivary Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer (NCT03146650) | Northwestern University | 2017-05-19 |
| Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510) | University of Washington | 2015-10-08 |
| Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385) | National Cancer Institute (NCI) | 2010-11-01 |
Track Stage IVB Major Salivary Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.